Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketum for Pain Tolerance in Chronic Users
NCT03414099Unknown
- Sponsor
- Universiti Sains Malaysia
- Start
- Jan 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in pain comparing Ketum with Placebo (2 arms). Primary endpoint: Pain tolerance at 3 hours. Status: unknown.
02
Drugs
ketum
03
Conditions
pain
Beyond the preview
Go deeper on NCT03414099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03414099.